VERA - NASDAQ

Vera Therapeutics, Inc.

VERA·NASDAQ

$32.75

+4.7%

HealthcareBiotechnology

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$2.35B

EPS-4.6600

P/E Ratio-7.03

Earnings Date08/04/2026

vera

Selling, General and Administrative Expenses

Last Annual Value

100.22M

3-Year CAGR

66%

5-Year CAGR

91%

10-Year CAGR

37%

Adjust for Inflation

Vera Therapeutics, Inc. Competitors Analysis of Selling, General and Administrative Expenses

VERA · NASDAQ

Company	Selling, General and Administrative Expenses	CAGR 3Y	CAGR 5Y	CAGR 10Y
Vera Therapeutics, Inc. NASDAQ:VERA	100.22M	61.5%	53.1%	N/A
Nuvation Bio Inc. NYSE:NUVB	151.56M	74.5%	44.2%	N/A
uniQure N.V. NASDAQ:QURE	65.34M	-3.7%	3.0%	9.7%
Janux Therapeutics, Inc. NASDAQ:JANX	41.77M	16.9%	32.2%	N/A
Immunome, Inc. NASDAQ:IMNM	43.77M	30.6%	31.6%	N/A
Celldex Therapeutics, Inc. NASDAQ:CLDX	43.80M	12.3%	16.4%	2.0%
Biohaven Ltd. NYSE:BHVN	106.17M	19.1%	23.2%	N/A
Harmony Biosciences Holdings, Inc. NASDAQ:HRMY	272.05M	12.2%	15.6%	N/A
Viridian Therapeutics, Inc. NASDAQ:VRDN	95.31M	0.1%	29.9%	25.8%

Vera Therapeutics, Inc. Fair Value Envelope

VERA · NASDAQ

Our analysis suggests that VERA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $32.75, this represents a potential HIDDEN relative to our calculated worth for Vera Therapeutics, Inc..

HIDDEN

Intrinsic Value

Current Price: $32.75

Related Guides

Blog Categories

Continue your VERA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.